Preeclampsia is a serious multisystem disorder that typically manifests as hypertension and proteinuria after 20 weeks’ gestation. The condition is multifactorial and involves placental, immunological, genetic, vascular, and maternal factors.

In Spain, preeclampsia affects about 1%-3% of pregnancies and, if not detected and managed early, can have severe or fatal consequences for both the mother and fetus.

Screening

First-trimester screening identifies patients at risk for early preeclampsia, defined as onset before 34 weeks of gestation, but there is no routine screening in the second or third trimester to detect late preeclampsia.

Standard first-trimester assessment combines maternal history, such as age, BMI, personal and family history of preeclampsia, diabetes, chronic hypertensi

See Full Page